119 results
Page 3 of 6
8-K
81fk8w
14 Jun 21
Gossamer Bio Announces Appointment of Sandra Milligan, M.D., J.D., to its Board of Directors
4:22pm
DEFA14A
qa6qbsb6rasqg3a
27 Apr 21
Additional proxy soliciting materials
4:18pm
8-K
EX-99.2
b79flqsrhx75jpx6izft
13 Oct 20
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
7:40am
8-K
dhu ynjjoq0ijsn5nmrn
18 Jun 20
Submission of Matters to a Vote of Security Holders
4:45pm
8-K
EX-1.2
waov8lb
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
EX-4.2
6gapiegsy
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
EX-1.1
4n3 tfsfb
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
EX-4.1
5ysbtwua8k451 5p
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
424B5
eg5e8sl02pct 44
19 May 20
Prospectus supplement for primary offering
5:11pm
424B5
iququk
19 May 20
Prospectus supplement for primary offering
5:08pm